[1]
|
Hegde, Y.M., Theivendren, P. and Srinivas, G. (2023) A Recent Advancement in Nanotechnology Approaches for the Treatment of Cervical Cancer. Anti-Cancer Agents in Medicinal Chemistry, 23, 37-59.
https://doi.org/10.2174/1871520622666220513160706
|
[2]
|
杨波, 秦月勤, 曹云桂, 等. 高危型人乳头瘤病毒E6/E7感染与宫颈病变组织中P16、ki67的相关性研究[J]. 中国妇产科临床杂志, 2023, 24(5): 514-515.
|
[3]
|
Viveros-Carreño, D., Fernandes, A. and Pareja, R. (2023) Updates on Cervical Cancer Prevention. In-ternational Journal of Gynecological Cancer, 33, 394-402. https://doi.org/10.1136/ijgc-2022-003703
|
[4]
|
Begliarzade, S. and Beilerli, A. (2023) Long Non-Coding RNAs as Promising Biomarkers and Therapeutic Targets in Cervical Cancer. Non-coding RNA Research, 8, 233-239. https://doi.org/10.1016/j.ncrna.2023.02.006
|
[5]
|
Dudea-Simon, M. and Mihu, D. (2022) Alteration of Gene and miRNA Expression in Cervical Intraepithelial Neoplasia and Cervical Cancer. International Journal of Molecular Sci-ences, 23, Article No. 6054.
https://doi.org/10.3390/ijms23116054
|
[6]
|
Buranjiang, G. and Abuduwanke, A. (2023) LncRNA HOTAIR En-hances RCC2 to Accelerate Cervical Cancer Progression by Sponging miR-331-3p. Clinical and Translational Oncolo-gy, 25, 1650-1660.
https://doi.org/10.1007/s12094-022-03059-4
|
[7]
|
Zhou, Y., Wang, Y. and Lin, M. (2021) LncRNA HOTAIR Promotes Proliferation and Inhibits Apoptosis by Sponging miR-214-3p in HPV16 Positive Cervical Cancer Cells. Can-cer Cell International, 21, Article No. 400.
https://doi.org/10.1186/s12935-021-02103-7
|
[8]
|
Liu, M.Y. and Li, N. (2023) The Diagnostic Value of lncRNA HOTAIR for Cervical Carcinoma in Vaginal Discharge and Serum. Medicine (Baltimore), 102, e34042. https://doi.org/10.1097/MD.0000000000034042
|
[9]
|
Zhang, X. and Mao, L. (2019) Long Noncoding RNA GIHCG Functions as an Oncogene and Serves as a Serum Diagnostic Biomarker for Cervical Cancer. Journal of Cancer, 10, 672-681. https://doi.org/10.7150/jca.28525
|
[10]
|
Zhu, Y. and Ren, C. (2022) Identification and Validation of the High Expression of Pseudogene TCAM1P in Cervical Cancer via Integrated Bioinformatics Analysis. Cancer Cell In-ternational, 22, Article No. 17.
https://doi.org/10.1186/s12935-021-02440-7
|
[11]
|
Liu, W., Yao, D. and Huang, B. (2021) LncRNA PVT1 Pro-motes Cervical Cancer Progression by Sponging miR-503 to Upregulate ARL2 Expression. Open Life Sciences, 16, 1-13. https://doi.org/10.1515/biol-2021-0002
|
[12]
|
Hao, C., Lin, S., Liu, P., Liang, W., Li, Z. and Li, Y. (2023) Po-tential Serum Metabolites and Long-Chain Noncoding RNA Biomarkers for Endometrial Cancer Tissue. Journal of Ob-stetrics and Gynaecology Research, 49, 725-743.
https://doi.org/10.1111/jog.15494
|
[13]
|
Xiong, S. and Song, H. (2023) LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p. Annals of Clinical & Laboratory Science, 53, 30-41.
|
[14]
|
Liang, M., Li, Y. and Chen, C. (2023) LMCD1-AS1 Facilitates Cell Proliferation and EMT by Sponging miR-873-3p in Cervical Can-cer. Critical Reviews™ in Eukaryotic Gene Expression, 33, 13-25.
https://doi.org/10.1615/CritRevEukaryotGeneExpr.2022042882
|
[15]
|
Liu, Y.Q., Liu, C. and Bai, Y. (2023) LncRNA AATBC Indicates Development and Facilitates Cell Growth and Metastasis of Cervical Cancer as a Sponge of miR-1245b-5p. The Kaohsiung Journal of Medical Sciences, 39, 115-123.
https://doi.org/10.1002/kjm2.12628
|
[16]
|
Zhang, K. and Ni, X. (2023) LINC01012 Upregulation Promotes Cervical Cancer Proliferation and Migration via Downregulation of CDKN2D. Oncology Letters, 25, Article No. 124. https://doi.org/10.3892/ol.2023.13710
|
[17]
|
El-Lateef, A.E.A. and El-Shemi, A.G.A. (2023) Analysis of Correlation between LncRNA TDRG1 Expression and Its Prognosis in Cervical Carcinoma Tissues. Applied Biochemistry and Bio-technology.
https://doi.org/10.1007/s12010-023-04496-9
|
[18]
|
Ding, X. and Jia, X. (2019) Correction to: A DHX9-lncRNA-MDM2 Interaction Regulates Cell Invasion and Angiogenesis of Cervical Cancer. Cell Death & Differ-entiation, 26, 2807. https://doi.org/10.1038/s41418-019-0273-1
|
[19]
|
阮立通, 邵志叶, 钱钢. HPV16-E6、E7蛋白在宫颈癌组织中的表达与病理特征的相关性[J]. 现代实用医学, 2021, 33(3): 297-299.
|
[20]
|
Wang, L. and Zhao, H. (2023) LncRNA CARMN Inhibits Cervical Cancer Cell Growth via the miR-92a-3p/BTG2/ Wnt/β-cateninaxis. Physio-logical Genomics, 55, 1-15. https://doi.org/10.1152/physiolgenomics.00088.2022
|
[21]
|
Yu, B. and Li, X. (2023) Post-Transcriptional Regulation of Tumor Suppressor Gene lncRNA CARMN via m6A Modification and miRNA Reg-ulation in Cervical Cancer. Journal of Cancer Research and Clinical Oncology, 149, 10307-10318. https://doi.org/10.1007/s00432-023-04893-x
|
[22]
|
Lan, L. and Liang, Z. (2020) LncRNA MCM3AP-AS1 Inhibits Cell Proliferation in Cervical Squamous Cell Carcinoma by Down-Regulating miRNA-93. Bioscience Reports, 40, BSR20193794. https://doi.org/10.1042/BSR20193794
|
[23]
|
Chi, C. and Hou, W. (2023) PDHB-AS Suppresses Cervical Cancer Progression and Cisplatin Resistance via Inhibition on Wnt/β-catenin Pathway. Cell Death & Disease, 14, Article No. 90. https://doi.org/10.1038/s41419-022-05547-5
|
[24]
|
阿小英, 郭桂兰. LncRNA MALAT1靶向miR124-3p/STAT3对宫颈癌细胞增殖和侵袭的影响[J]. 中国妇产科临床杂志, 2021, 22(3): 267-269.
|
[25]
|
Liang, T., Wang, Y. and Jiao, Y. (2021) LncRNA MALAT1 Accelerates Cervical Carcinoma Proliferation by Suppressing miR-124 Expression in Cervical Tumor Cells. Journal of Oncology, 2021, Article ID: 8836078.
https://doi.org/10.1155/2021/8836078
|
[26]
|
Yan, K. and Hu, C. (2023) LncRNA CERS6-AS1, Sponging miR-6838-5p, Promotes Proliferation and Invasion in Cervical Carcinoma Cells by Upregulating FOXP2. Histology and Histopathology, 38, 823-835.
|
[27]
|
Gan, Q. and Huang, X. (2023) AC010883.5 Promotes Cell Proliferation, Invasion, Migration, and Epithelial-to-Mesenchymal Transition in Cervical Cancer by Modulating the MAPK Signaling Pathway. BMC Cancer, 23, Article No. 364. https://doi.org/10.1186/s12885-023-10825-2
|
[28]
|
Hu, Y. and Li, G. (2023) Ef-fect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 Positive Feedback Loop on PI3K/Akt Pathway Mediating Cisplatin Resistance in Cervical Cancer Cells. Journal of Oncology, 2023, Article ID: 6341011. https://doi.org/10.1155/2023/6341011
|
[29]
|
Liu, Y.J. and Guo, R.X. (2020) Effect of CASC19 on Proliferation, Apoptosis and Radiation Sensitivity of Cervical Cancer Cells by Regulating miR-449b-5p Expression. Chinese Journal of Obstetrics and Gynecology, 55, 36-44.
|
[30]
|
Zhang, W. and Wu, Q. (2022) LncRNA HOTAIR Promotes Chemo-resistance by Facilitating Epithelial to Mesenchymal Transition through miR-29b/PTEN/PI3K Signaling in Cervical Can-cer. Cells Tissues Organs, 211, 16-29.
https://doi.org/10.1159/000519844
|
[31]
|
Gao, J. and Liu, L. (2019) LncRNA GAS5 Confers the Radio Sensitivity of Cervical Cancer Cells via Regulating miR-106b/IER3 Axis. International Journal of Biological Macromolecules, 126, 994-1001.
https://doi.org/10.1016/j.ijbiomac.2018.12.176
|
[32]
|
Zhang, Y. and Zheng, M. (2023) Correction: LncRNA LOXL1-AS1 Facilitates the Oncogenic Character in Cervical Cancer by the miR-526b-5p/LYPLA1 Axis. Biochemical Genetics, 61, 448.
https://doi.org/10.1007/s10528-022-10301-9
|
[33]
|
Wang, X. and Wang, Z. (2017) LncRNA MEG3 Has An-ti-Activity Effects of Cervical Cancer. Biomedicine & Pharmacotherapy, 94, 636-643. https://doi.org/10.1016/j.biopha.2017.07.056
|
[34]
|
Yu, M. and Xue, S. (2023) Long Non-Coding RNA UCA1a Promotes Proliferation via PKM2 in Cervical Cancer. Reproductive Sciences, 30, 601-614. https://doi.org/10.1007/s43032-022-01042-6
|
[35]
|
Shen, S. and Jin, H. (2023) LINC00426, a Novel m6A-Regulated Long Non-Coding RNA, Induces EMT in Cervical Cancer by Binding to ZEB1. Cell Signaling, 109, Article ID: 110788. https://doi.org/10.1016/j.cellsig.2023.110788
|
[36]
|
Moazeni-Roodi, A. and Aftabi, S. (2020) Genetic Association between HOTAIR Gene and the Risk of Cancer: An Updated Meta-Analysis. Journal of Genetics, 99, Article No. 48. https://doi.org/10.1007/s12041-020-01214-w
|
[37]
|
Yao, Y. and Liang, Y. (2022) Association of Long Non-Coding RNAs (lncRNAs) ANRIL and MALAT1 Polymorphism with Cervical Cancer. Pharmacogenomics and Personalized Medicine, 15, 359-375.
https://doi.org/10.2147/PGPM.S358453
|